Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors.

Saved in:
Bibliographic Details
Title: Allogeneic cetuximab-armed gamma delta T cells using antibody-cell conjugation technology for the treatment of EGFR-expressing solid tumors.
Authors: Li HK; Acepodia Biotech Inc, Alameda, California, USA., Wu TS; Acepodia Biotech Inc, Alameda, California, USA., Ru Y; Acepodia Biotech Inc, Alameda, California, USA., Kuo YC; Acepodia Biotech Inc, Alameda, California, USA., Lee CY; Acepodia Biotech Inc, Alameda, California, USA., Leng PJ; Acepodia Biotech Inc, Alameda, California, USA., Hsieh YC; Acepodia Biotech Inc, Alameda, California, USA., Chiang YJ; Acepodia Biotech Inc, Alameda, California, USA., Cheng ZF; Acepodia Biotech Inc, Alameda, California, USA., Lin YL; Acepodia Biotech Inc, Alameda, California, USA., Hsiao SC; Acepodia Biotech Inc, Alameda, California, USA saiwen@acepodiabio.com sonny@acepodiabio.com., Tang SW; Acepodia Biotech Inc, Alameda, California, USA saiwen@acepodiabio.com sonny@acepodiabio.com.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Jul 15; Vol. 13 (7). Date of Electronic Publication: 2025 Jul 15.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1136/jitc-2024-010500